论文部分内容阅读
目的分析使用尿激酶溶栓对脑血栓形成的治疗效果。方法 110例脑血栓患者,通过入院先后顺序分成对照组(使用常规药物治疗)和观察组(在对照组的基础上使用尿激酶进行治疗),各55例。比较两组患者治疗效果。结果观察组治疗总有效率96.36%明显高于对照组61.82%,差异具有统计学意义(χ2=19.845,P<0.05)。观察组神经功能缺损评分为(15.01±2.87)分,低于对照组的(22.19±6.71)分,差异具有统计学意义(t=7.2963,P<0.05)。结论与常规药物治疗相比尿激酶对脑血栓的治疗效果更佳,实现对脑血栓形成的有效控制,降低病症对患者造成的风险。
Objective To analyze the therapeutic effect of urokinase thrombolysis on cerebral thrombosis. Methods One hundred and thirteen patients with cerebral thrombosis were divided into control group (treated with conventional medicine) and observation group (treated with urokinase on the basis of the control group), 55 cases in each group. Compare the treatment effect of two groups of patients. Results The total effective rate of observation group was 96.36%, significantly higher than 61.82% of control group, the difference was statistically significant (χ2 = 19.845, P <0.05). The score of neurological deficit in the observation group was (15.01 ± 2.87) points, which was lower than that of the control group (22.19 ± 6.71), the difference was statistically significant (t = 7.2963, P <0.05). Conclusion Compared with conventional drug therapy, urokinase has a better therapeutic effect on cerebral thrombosis, which can effectively control cerebral thrombosis and reduce the risk to patients.